Library
Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates in Refractory mCRC at ESMO 21st World GI Congress
Celyad Announces April 2019 Investor Conference Schedule
Celyad Announces April 2019 Investor Conference Schedule
Celyad Reports Business Update and Full Year 2018 Financial and Operating Results
Celyad Reports Business Update and Full Year 2018 Financial and Operating Results
Celyad Appoints Filippo Petti as Chief Executive Officer
Celyad Appoints Filippo Petti as Chief Executive Officer
Celyad to Announce Full Year 2018 Financial Results and Host Conference Call
Celyad to Announce Full Year 2018 Financial Results and Host Conference Call
Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates
Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates
Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City
Celyad to Host R&D Day and Webcast on Monday, March 18 in New York City
Celyad Appoints Anne Moore as Vice President Corporate Strategy
Celyad Appoints Anne Moore as Vice President Corporate Strategy
Celyad Announces February and March 2019 Investor Conference Schedule
Celyad Announces February and March 2019 Investor Conference Schedule
Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS
Celyad Outlines Key 2019 Priorities Including the Acceleration of the CYAD-01 Program in r/r AML and MDS